CDCA5 and hepatocellular carcinoma: Moreover, CDCA5 was shown to be upregulated in hepatocellular carcinoma (HCC) tissues compared to paracancerous tissues, is negatively correlated with patient survival and associated with cell abnormalities via upregulation of the AKT pathway[45].